Acceptance of short course artesunate plus mefloquine drug combination by malaria patients in rural Myanmar.
dc.contributor.author | Win, L L | en_US |
dc.contributor.author | Shwe, T | en_US |
dc.contributor.author | Lwin, M | en_US |
dc.contributor.author | Aung, S | en_US |
dc.contributor.author | Zaw, A K | en_US |
dc.contributor.author | Mar, K K | en_US |
dc.date.accessioned | 2009-05-27T15:29:17Z | |
dc.date.available | 2009-05-27T15:29:17Z | |
dc.date.issued | 1999-09-25 | en_US |
dc.description | The Southeast Asian Journal of Tropical Medicine and Public Health. | en_US |
dc.description.abstract | A cross sectional study was carried out in a rural area of Myanmar to identify malaria patients' acceptance of artesunate plus mefloquine drug combination and to determine the cost borne by patients. The majority (88.5%) preferred this new regimen rather than the other ones they had used before; conviction of drug efficacy was the reason given for the preference by most of them. Traveling on foot to rural health centers or a health assistant's residence for getting the drugs was found to be the main route. Average cost incurred by a patient to get the drug was found to be 274.22 Kyats. Among the cost items, drug cost was the highest item that they had used. | en_US |
dc.description.affiliation | Department of Medical Research, Ministry of Health, Myanmar. | en_US |
dc.identifier.citation | Win LL, Shwe T, Lwin M, Aung S, Zaw AK, Mar KK. Acceptance of short course artesunate plus mefloquine drug combination by malaria patients in rural Myanmar. The Southeast Asian Journal of Tropical Medicine and Public Health. 1999 Sep; 30(3): 418-20 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/32905 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.tm.mahidol.ac.th/seameo/1999-30-3/1999-30-3-418.pdf | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Antimalarials --economics | en_US |
dc.subject.mesh | Artemisinins | en_US |
dc.subject.mesh | Cross-Sectional Studies | en_US |
dc.subject.mesh | Drug Combinations | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Health Care Costs | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Malaria, Falciparum --drug therapy | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mefloquine --economics | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Myanmar --epidemiology | en_US |
dc.subject.mesh | Patient Compliance | en_US |
dc.subject.mesh | Rural Population | en_US |
dc.subject.mesh | Sesquiterpenes --economics | en_US |
dc.title | Acceptance of short course artesunate plus mefloquine drug combination by malaria patients in rural Myanmar. | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, Non-U.S. Gov't | en_US |